---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-145194"
form_type: "8-K"
ticker: "IRWD"
cik: "0001446847"
company_name: "IRONWOOD PHARMACEUTICALS INC"
filed_at: "2021-12-01T23:59:59+00:00"
generated_at: "2026-06-28T04:25:49.581423+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ironwood appoints Sravan Emany as CFO, effective Dec 6, 2021

## Summary
- Sravan K. Emany named SVP, CFO effective Dec 6, 2021; Jason Rickard remains COO.
- Emany previously corporate VP at Integra LifeSciences and managing director at BofA.
- Base salary $500k, bonus target 50% of base, $200k sign-on bonus, 85k RSUs and 85k PSUs.
- Emany to enter indemnification and executive severance agreement (filed as Exhibit 10.1).

## SEC filing metadata
- accession: 0001104659-21-145194
- form_type: 8-K
- ticker: IRWD
- cik: 0001446847
- company_name: IRONWOOD PHARMACEUTICALS INC
- filed_at: 2021-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/0001104659-21-145194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/tm2134154d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-145194
- JSON: https://secwatch.observer/filing/0001104659-21-145194.json
- Plain text: https://secwatch.observer/filing/0001104659-21-145194.txt

## Key facts
- Executive change
  Sravan K. Emany was appointed as Senior Vice President, Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer
  source text: On November 29, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) appointed Sravan K. Emany, 44, as the Company’s Senior Vice President, Chief Financial Officer, effective December 6, 2021 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/0001104659-21-145194-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.